Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Gabapentin NDC 70518-2356 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

MM2 - Gabapentin 600mg 70518 2356 01

MM2 - Gabapentin 600mg 70518 2356 01

Gabapentin is a medication that can only be obtained with a prescription. It has an NDC number of 70518-2356-01 and is manufactured by Aurobindo in India. The lot number and expiration date are not available. This medication should be kept out of reach of children and stored at a temperature of 20-26°C. Directions for use can be found in the package insert. The medication has been repackaged by RemedyRepack Inc. in Indiana.*

Gabapentin 600mg 70518 2356 02

Gabapentin 600mg 70518 2356 02

Gabapentin is a prescription-only medication manufactured by Aurcbindo in India, with the source NDC being 65862-0523-05. The medication is sold in a box with an NDC number of 70518-2356-02 and the lot number and expiration date printed on it. The medication should be stored at a temperature between 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F) as per USP. The medication should be kept out of reach of children, and the directions for use should be followed as per the package insert. It has been repackaged by RemedyRepack Inc. in Indiana.*

Gabapentin 600mg 70518 2356 03

Gabapentin 600mg 70518 2356 03

Gabapentin is a prescription-only drug manufactured in India. The drug is repackaged by a US-based company for sale in the US. The direction to use can be found in the package insert. The medication should be stored at a temperature range of 20-26°C and kept away from children. The expiry date and lot number are not available in the given text.*

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Gabapentin is a prescription-only medication that is packaged by RemedyRepack Inc. in Indiana, PA. It is manufactured by Aurcbindo in India and has an NDC number of 70518-2356-00. The drug should be stored between 20-26°C (63-77°F) with excursions up to 15-30°C (59-86°F) and kept out of the reach of children. The package insert should be followed for directions on use. The expiration date and lot number are not available from the text.*

Creatinine clearance - gabapentin fig1

Creatinine clearance - gabapentin fig1

This appears to be a medical formula for calculating something called "Lt" using a patient's age, weight and creatinine levels. However, without more context it is difficult to determine exactly what the formula is used for.*

Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - gabapentin fig2

Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - gabapentin fig2

This is a graph showing the weekly mean pain scores for observed cases in an ITT population for Study 1. The x-axis shows different time points (ek, Do, Tuon, Priod, Fred, Dose, Prci) and the y-axis shows the mean pain score. The graph compares the pain score for a placebo group and a group taking Gabapentin at a dose of 300 mg/day.*

Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - gabapentin fig3

Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - gabapentin fig3

Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin fig4

Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin fig4

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5

Chemical Structure - gabapentin str

Chemical Structure - gabapentin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.